Vitreoretinal research review November 2025
Dr Moaz Alshaikhi reviews three retinal studies including one on a new sustained-release anti-VEGF treatment
Dr Moaz Alshaikhi5 min read
Advertisement
Dr Moaz Alshaikhi reviews three retinal studies including one on a new sustained-release anti-VEGF treatment
Link: https://www.nzoptics.co.nz/live-articles/save-sight-symposium-2024-ideas-and-innovations-in-eye-health/
https://nzoptics.co.nz/live-articles/ccls-2025-talking-collaboration/
https://www.nzoptics.co.nz/live-articles/covid-associated-with-amn-spike/
Central serous chorioretinopathy (CSCR) is a commonly encountered chorioretinal disorder affecting working-age adults, the majority of whom (especially in acute presentations) achieve spontaneous resolution of subretinal fluid and visual improvement within three to six months1.
Central serous chorioretinopathy (CSCR), characterised by serous detachment of the neurosensory retina and detachments of an altered retinal pigment epithelium (RPE), can be frustrating for both patie
In choosing from the expanding list of options for glaucoma surgery, we should be seeking to optimise efficacy, safety and consider costs. An ideal glaucoma operation immediately results in: a stable
A recent pilot showed strengthened referral pathways increase access to support for people living with low vision or blindness.
British actress Phyllida Law (93) has glaucoma and worries her daughters – actresses Emma and Sophie Thompson – will go blind, just like her own mother did.
While most cases of dry eye disease respond well to established treatments, there is a subset with severe dry eye that may need other options. Serum eye drops have been successfully used for decades for conditions including persistent epithelial defects and neurotrophic keratopathy. Increasingly, th
A standardised protocol for tear meniscus height, a critical aetiological indicator of aqueous-deficient dry eye
David Slack on his dad's cataract surgery and the eyecare professionals who make it all possible